Disposable syringe with unit markings for the dosage and administration of refined forms of botulinum toxin A

Solomon September 24, 2

Patent Grant D690417

U.S. patent number D690,417 [Application Number D/435,177] was granted by the patent office on 2013-09-24 for disposable syringe with unit markings for the dosage and administration of refined forms of botulinum toxin a. The grantee listed for this patent is Sid Solomon. Invention is credited to Sid Solomon.


United States Patent D690,417
Solomon September 24, 2013

Disposable syringe with unit markings for the dosage and administration of refined forms of botulinum toxin A

Claims

CLAIM I claim the ornamental design for a disposable syringe with unit markings for the dosage and administration of refined forms of botulinum toxin A, as shown and described.
Inventors: Solomon; Sid (Los Angeles, CA)
Applicant:
Name City State Country Type

Solomon; Sid

Los Angeles

CA

US
Appl. No.: D/435,177
Filed: October 19, 2012

Current U.S. Class: D24/114
Current International Class: 2402
Field of Search: ;D24/112-114,133,186,104,130,127 ;606/181,185 ;604/264,272,115,232,187,158,164.08,192,263,163,181,184,198,227

References Cited [Referenced By]

U.S. Patent Documents
D188927 September 1960 Burke
2972991 February 1961 Burke
3216616 November 1965 Blankenship, Jr.
3320954 May 1967 Cowley
3391694 July 1968 Spaeth
D252586 August 1979 Kovach
D258454 March 1981 Echevarria et al.
5294325 March 1994 Liu
5651774 July 1997 Taranto et al.
D436661 January 2001 Berry
6432087 August 2002 Hoeck et al.
6936034 August 2005 Watkins
D545429 June 2007 Hays
D552773 October 2007 Greenberg
D557337 December 2007 Isaacs
D597204 July 2009 Oberlaender et al.
7582073 September 2009 Barrelle et al.
D626216 October 2010 Tyce
7938800 May 2011 Koh
D657867 April 2012 Effenberger
2008/0114305 May 2008 Gerondale
2010/0130961 May 2010 Tucker
Primary Examiner: Muller; David
Attorney, Agent or Firm: QuickPatents Prince; Kevin

Description



FIG. 1 is a perspective view of a disposable syringe with unit markings for the dosage and administration of refined forms of botulinum toxin A, showing my new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a bottom plan view thereof;

FIG. 4 is a left-side elevational view thereof, the right-side elevational view being a mirror image thereof;

FIG. 5 is a front elevational view thereof; and,

FIG. 6 is a rear elevational view thereof.

The broken lines showing a logo in FIGS. 1 and 2 depict environmental matter and form no part of the claimed design.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed